2. Academic Validation
  3. The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

  • Nat Commun. 2014 Dec 9;5:5705. doi: 10.1038/ncomms6705.
Geeta Sapra 1,  Yow Keat Tham 1,  Nelly Cemerlang 1,  Aya Matsumoto 1,  Helen Kiriazis 1,  Bianca C Bernardo 1,  Darren C Henstridge 1,  Jenny Y Y Ooi 1,  Lynette Pretorius 2,  Esther J H Boey 1,  Lydia Lim 1,  Junichi Sadoshima 3,  Peter J Meikle 1,  Natalie A Mellet 1,  Elizabeth A Woodcock 1,  Silvana Marasco 4,  Tomomi Ueyama 5,  Xiao-Jun Du 1,  Mark A Febbraio 2,  Julie R McMullen 2
Affiliations

Affiliations

  • 1 Baker IDI Heart and Diabetes Institute, PO Box 6492, Melbourne, Victoria 3004, Australia.
  • 2 1] Baker IDI Heart and Diabetes Institute, PO Box 6492, Melbourne, Victoria 3004, Australia [2] Monash University, Melbourne, Victoria 3800, Australia.
  • 3 Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, The State University of New Jersey, Newark, New Jersey 07103, USA.
  • 4 Heart Centre, Alfred Hospital, Melbourne, Victoria 3004, Australia.
  • 5 Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
PMID: 25489988 DOI: 10.1038/ncomms6705
Abstract

Heart failure (HF) and atrial fibrillation (AF) share common risk factors, frequently coexist and are associated with high mortality. Treatment of HF with AF represents a major unmet need. Here we show that a small molecule, BGP-15, improves cardiac function and reduces arrhythmic episodes in two independent mouse models, which progressively develop HF and AF. In these models, BGP-15 treatment is associated with increased phosphorylation of the insulin-like growth factor 1 receptor (IGF1R), which is depressed in atrial tissue samples from patients with AF. Cardiac-specific IGF1R transgenic overexpression in mice with HF and AF recapitulates the protection observed with BGP-15. We further demonstrate that BGP-15 and IGF1R can provide protection independent of phosphoinositide 3-kinase-Akt and heat-shock protein 70; signalling mediators often defective in the aged and diseased heart. As BGP-15 is safe and well tolerated in humans, this study uncovers a potential therapeutic approach for HF and AF.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z